- Home
- COE vs FBRX Comparison
COE vs FBRX Comparison
Compare COE & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COE
- FBRX
- Stock Information
- Founded
- COE 2011
- FBRX N/A
- Country
- COE Singapore
- FBRX United States
- Employees
- COE N/A
- FBRX N/A
- Industry
- COE Other Consumer Services
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- COE Real Estate
- FBRX Health Care
- Exchange
- COE Nasdaq
- FBRX Nasdaq
- Market Cap
- COE 177.0M
- FBRX 154.5M
- IPO Year
- COE 2016
- FBRX N/A
- Fundamental
- Price
- COE $35.33
- FBRX $11.43
- Analyst Decision
- COE
- FBRX Strong Buy
- Analyst Count
- COE 0
- FBRX 3
- Target Price
- COE N/A
- FBRX $68.00
- AVG Volume (30 Days)
- COE 14.7K
- FBRX 59.5K
- Earning Date
- COE 08-29-2025
- FBRX 08-14-2025
- Dividend Yield
- COE N/A
- FBRX N/A
- EPS Growth
- COE N/A
- FBRX N/A
- EPS
- COE N/A
- FBRX N/A
- Revenue
- COE $59,490,000.00
- FBRX N/A
- Revenue This Year
- COE N/A
- FBRX N/A
- Revenue Next Year
- COE N/A
- FBRX N/A
- P/E Ratio
- COE N/A
- FBRX N/A
- Revenue Growth
- COE 91.87
- FBRX N/A
- 52 Week Low
- COE $12.11
- FBRX $4.11
- 52 Week High
- COE $46.79
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- COE 71.96
- FBRX 54.64
- Support Level
- COE $32.70
- FBRX $9.91
- Resistance Level
- COE $46.79
- FBRX $13.63
- Average True Range (ATR)
- COE 3.13
- FBRX 0.92
- MACD
- COE 0.24
- FBRX 0.14
- Stochastic Oscillator
- COE 49.54
- FBRX 51.43
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).